Price Alert

Silence Therapeutics (SLN)

NASDAQ: SLN · Real-Time Price · USD

5.48

-0.15 (-2.66%)

At close: Aug 15, 2025, 3:59 PM

5.49

0.09%

After-hours: Aug 15, 2025, 04:10 PM EDT

Silence Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	64.89M	121.33M	82.91M	109.48M	113.06M	54.03M	58.81M	29.72M	46.73M	54.82M	90.02M	51.56M	59.3M	73.54M	71.47M	71.24M	-37.45M
Short-Term Investments	71.65M	26M	67.04M	40.11M	39.7M	n/a	n/a	20.5M	16.14M	16.33M	n/a	n/a	n/a	n/a	5M	10M	74.9M
Long-Term Investments	n/a	n/a	380.05K	284K	284K	284K	284K	284K	284K	284K	284K	303K	301K	301K	302K	301K	n/a
Other Long-Term Assets	3.61M	3.23M	-1.15M	2.36M	2.56M	2.58M	n/a	-10.4M	-10.66M	-10.81M	-10.58M	-9.96M	n/a	n/a	5M	10M	-37.45M
Receivables	16.84M	26.91M	16.56M	1.69M	8.14M	18.83M	462K	12.32M	1.69M	17.34M	130K	2.9M	2.57M	8.49M	n/a	438K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-18.61M	n/a	n/a	n/a	-16.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	16.42M	40.03M	16.01M	25.1M	20.84M	n/a	28.33M	19.77M	19.12M	n/a	23.31M	18.98M	15.04M	n/a	6.66M	9.67M	n/a
Total Current Assets	169.79M	187.37M	157.51M	176.38M	181.73M	81.02M	87.6M	82.31M	83.68M	96.69M	113.46M	73.45M	76.91M	86.33M	83.13M	91.35M	37.45M
Property-Plant & Equipment	1.8M	2.33M	2.2M	1.69M	1.79M	1.81M	1.93M	2.04M	2.1M	2.2M	2.32M	1.85M	1.9M	1.94M	1.53M	1.31M	n/a
Goodwill & Intangibles	10.09M	9.7M	10.43M	7.93M	8.01M	8.12M	8.13M	8.07M	8.27M	8.33M	7.98M	7.8M	7.68M	7.62M	7.79M	7.77M	n/a
Total Long-Term Assets	15.51M	15.27M	11.87M	12.26M	12.65M	12.8M	10.34M	10.4M	10.66M	10.81M	10.58M	9.96M	9.88M	9.86M	9.63M	9.38M	-37.45M
Total Assets	185.3M	202.63M	169.38M	188.64M	194.38M	93.82M	97.94M	92.71M	94.34M	107.5M	124.04M	83.4M	86.78M	96.19M	92.75M	100.72M	n/a
Account Payables	18.81M	3.7M	14.27M	14.99M	10.49M	2.63M	11.95M	12.2M	13.25M	3.19M	14.81M	11.7M	7.68M	4.07M	9.24M	7.87M	n/a
Deferred Revenue	392K	306K	3.35M	2.77M	3.5M	5.16M	5.87M	7.16M	4.34M	8.86M	10.62M	7.81M	7.95M	4.25M	9.03M	6.72M	n/a
Short-Term Debt	60K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	3.44M	47.01K	n/a	n/a	373K	n/a	n/a	n/a	589K	n/a	n/a	n/a	185K	n/a	n/a	n/a
Total Current Liabilities	19.26M	16.82M	22.63M	17.94M	14.18M	17.77M	18.02M	19.56M	17.76M	21.94M	25.93M	19.56M	15.73M	15.17M	18.4M	14.76M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	53.29M	51.79M	57.95M	58.19M	56.3M	59M	59.93M	60.9M	59.98M	63.48M	63.97M	68.59M	67.07M	72.5M	58M	62.29M	n/a
Total Liabilities	72.56M	68.61M	74.87M	76.13M	70.48M	76.77M	77.94M	80.45M	77.75M	85.43M	89.91M	88.14M	82.79M	87.67M	76.39M	77.06M	n/a
Total Debt	60K	117K	139K	184K	277K	272K	315K	364K	398K	446K	499K	52K	90K	137K	131K	179K	n/a
Common Stock	10.29M	10.29M	7.08M	7.02M	6.99M	5.94M	5.8M	5.51M	5.4M	5.39M	5.38M	4.49M	4.49M	4.49M	4.49M	4.49M	n/a
Retained Earnings	-502.54M	-474.04M	-463.89M	-320.15M	-305.7M	-304.61M	-290.61M	-282.76M	-272.41M	-263.26M	-249.64M	-242.56M	-230.65M	-222.97M	-213.55M	-203.68M	n/a
Comprehensive Income	-8.08M	-11.78M	23.96M	68.76M	24.11M	24.2M	24.2M	24.14M	24.29M	24.33M	24.48M	23.97M	23.87M	23.79M	24.03M	24.01M	9.06M
Shareholders Equity	112.74M	134.02M	126.48M	112.51M	123.9M	17.05M	20M	12.26M	16.59M	22.07M	34.13M	-4.74M	3.99M	8.53M	16.36M	23.67M	9.06M
Total Investments	71.65M	26M	67.32M	40.4M	39.98M	284K	284K	20.79M	16.42M	16.61M	284K	303K	301K	301K	302K	301K	74.9M